INSTITUTO ROSENBUCH SA DE BIOLOGIAINSTITUTO ROSENBUCH SA DE BIOLOGIAINSTITUTO ROSENBUCH SA DE BIOLOGIA

INSTITUTO ROSENBUCH SA DE BIOLOGIA

No trades
See on Supercharts

ROSE fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Instituto Rosenbusch SA engages in the manufacture and marketing of veterinary products. It operates through the following business segments: Biological Products, Pharmaceutical Products, and Others. The Biological Products segment includes products for reproductive-respiratory complex, brucellosis and carbuncle, clostridial and other vaccines, horses, pneumonia and calve diarrhea, and queratoconjuntivitis. The Pharmaceutical Products segment includes antimastitics, antimicotics-bacteriostatics, endectocides, external antiparasitics, injectable antibiotics, internal antiparasitics, other chemotherapics, and vitamins and minerals. The company was founded by Francisco Conrado Rosenbusch in 1917 and is headquartered in Buenos Aires, Argentina.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

ROSE does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company